JP2014062109A5 - - Google Patents

Download PDF

Info

Publication number
JP2014062109A5
JP2014062109A5 JP2013246532A JP2013246532A JP2014062109A5 JP 2014062109 A5 JP2014062109 A5 JP 2014062109A5 JP 2013246532 A JP2013246532 A JP 2013246532A JP 2013246532 A JP2013246532 A JP 2013246532A JP 2014062109 A5 JP2014062109 A5 JP 2014062109A5
Authority
JP
Japan
Prior art keywords
component
weight
use according
salts
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013246532A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014062109A (ja
JP5766258B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013246532A priority Critical patent/JP5766258B2/ja
Priority claimed from JP2013246532A external-priority patent/JP5766258B2/ja
Publication of JP2014062109A publication Critical patent/JP2014062109A/ja
Publication of JP2014062109A5 publication Critical patent/JP2014062109A5/ja
Application granted granted Critical
Publication of JP5766258B2 publication Critical patent/JP5766258B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2013246532A 2004-09-22 2013-11-28 色素沈着予防又は改善剤 Expired - Lifetime JP5766258B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013246532A JP5766258B2 (ja) 2004-09-22 2013-11-28 色素沈着予防又は改善剤

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2004274454 2004-09-22
JP2004274454 2004-09-22
JP2004376562 2004-12-27
JP2004376562 2004-12-27
JP2013246532A JP5766258B2 (ja) 2004-09-22 2013-11-28 色素沈着予防又は改善剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012144388A Division JP5514268B2 (ja) 2004-09-22 2012-06-27 色素沈着予防又は改善剤

Publications (3)

Publication Number Publication Date
JP2014062109A JP2014062109A (ja) 2014-04-10
JP2014062109A5 true JP2014062109A5 (https=) 2014-05-22
JP5766258B2 JP5766258B2 (ja) 2015-08-19

Family

ID=47011852

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012144388A Expired - Lifetime JP5514268B2 (ja) 2004-09-22 2012-06-27 色素沈着予防又は改善剤
JP2013246532A Expired - Lifetime JP5766258B2 (ja) 2004-09-22 2013-11-28 色素沈着予防又は改善剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012144388A Expired - Lifetime JP5514268B2 (ja) 2004-09-22 2012-06-27 色素沈着予防又は改善剤

Country Status (1)

Country Link
JP (2) JP5514268B2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5514268B2 (ja) * 2004-09-22 2014-06-04 大塚製薬株式会社 色素沈着予防又は改善剤
JP6430109B2 (ja) * 2012-11-02 2018-11-28 ロート製薬株式会社 外用組成物
JP6057697B2 (ja) * 2012-12-25 2017-01-11 株式会社マンダム 皮膚用乳化組成物
JP6166544B2 (ja) * 2013-02-13 2017-07-19 第一三共ヘルスケア株式会社 色素沈着症の予防又は治療剤
JP6180816B2 (ja) * 2013-06-24 2017-08-16 ポーラ化成工業株式会社 皮膚外用剤
WO2019151276A1 (ja) * 2018-01-31 2019-08-08 大塚製薬株式会社 アデノシンリン酸およびトラネキサム酸含有外用組成物の変色抑制方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5093998B2 (ja) * 2004-09-22 2012-12-12 大塚製薬株式会社 色素沈着予防又は改善剤
JP5514268B2 (ja) * 2004-09-22 2014-06-04 大塚製薬株式会社 色素沈着予防又は改善剤

Similar Documents

Publication Publication Date Title
JP2014062109A5 (https=)
CA2894891A1 (en) Boronic acid derivatives and therapeutic uses thereof
EP2833721A4 (en) NICKEL OXIDE RELEASING PHARMACEUTICAL COMPOSITIONS
BR112015014372A2 (pt) inibidores de autotaxina
HUE043540T2 (hu) Szubsztituált dimer kinazolin-származék, elõállítása, valamint alkalmazása 1-es és 2-es típusú cukorbetegség kezelésére szolgáló gyógyászati készítményekben
CA2894892A1 (en) Boronic acid derivatives and therapeutic uses thereof
BR112014014262A2 (pt) nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas.
JP2015078230A5 (https=)
CL2014002757A1 (es) Compuestos derivados de benzamida para inhibir la actividad de abl1, abl2 y bcr-abl1, composicion farmaceutica; y uso en el tratamiento del cancer.
JP2013014622A5 (https=)
CL2016002132A1 (es) Uso de una cantidad de laquinimod, que sirve para preparar un medicamento para tratar un paciente humano afectado con esclerosis múltiple o que presenta un síndrome clínicamente aislado; un paquete, una cantidad de laquinimod y una composición farmacéutica del mismo.
EA201500742A1 (ru) Защищенные от нецелевого использования фармацевтические композиции
BR112015017251A8 (pt) composições farmacêuticas compreendendo doadores de nitroxil, misturas e usos das referidas composições farmacêuticas
HRP20191523T1 (hr) Paraziticidne kombinacije spirocikličkog izoksazolina
IL232764A (en) Fluoromethyl6,5 - Dihydro - 4 H - [3,1] Oxazines, Pharmaceuticals Containing Them and Their Use in the Preparation of Medicines to Treat Alzheimer's Disease
BR112015001207A8 (pt) derivados de carbamato/ureia, seus usos, composição farmacêutica, forma livre e seu método de preparação
EP2830698A4 (en) NITROGEN OXIDE RELEASE DEVICES
RU2017141536A (ru) Замещенные производные индол-5-ола и их терапевтические применения
WO2016040814A3 (en) Disulfide polymers and methods of use
JP2016538288A5 (https=)
JP2011157392A5 (https=)
JP2015500340A5 (https=)
JP2017517574A5 (https=)
SMT201700395T1 (it) Composizioni farmaceutiche comprendenti acido ialuronico per il trattamento della patologia del black disc
FR3011736B1 (fr) Seringue d'administration orale de produit